Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Return on Sales (2016 - 2025)

Tandem Diabetes Care's Return on Sales history spans 13 years, with the latest figure at 0.0% for Q4 2025.

  • For Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.2%, down 10.0%, while the annual FY2025 figure was 0.2%, 10.0% down from the prior year.
  • Return on Sales reached 0.0% in Q4 2025 per TNDM's latest filing, up from 0.08% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.05% in Q4 2021 to a low of 0.73% in Q1 2023.
  • Average Return on Sales over 5 years is 0.15%, with a median of 0.09% recorded in 2024.
  • Peak YoY movement for Return on Sales: plummeted -65bps in 2023, then surged 51bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.05% in 2021, then plummeted by -241bps to 0.07% in 2022, then plummeted by -111bps to 0.15% in 2023, then surged by 102bps to 0.0% in 2024, then tumbled by -164bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Return on Sales are 0.0% (Q4 2025), 0.08% (Q3 2025), and 0.22% (Q2 2025).